Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Filip Krag Knop

Filip Krag Knop

Chief Consultant

Niels Steensens Vej 2-4

2820 Gentofte

Denmark

​Gentofte Hospital

Building: Opgang ​7, 3. sal, Kildegårdsvej 28

2900 Hellerup

Denmark

  1. 2013
  2. Published

    Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction

    Knop, F. K. & Taylor, R., Aug 2013, In : Diabetes Care. 36 Suppl 2, p. S287-91

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus

    Bonde, L., Vilsbøll, T., Nielsen, T., Bagger, J. I., Svare, J. A., Holst, J., Larsen, S. & Knop, F. K., Aug 2013, In : Diabetes, Obesity and Metabolism. 15, 8, p. 713-20 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published
  5. Published

    The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty

    Plamboeck, A., Veedfald, S., Deacon, C. F., Hartmann, B., Wettergren, A., Svendsen, L. B., Meisner, S., Hovendal, C., Vilsbøll, T., Knop, F. K. & Holst, J. J., Jun 2013, In : A J P: Gastrointestinal and Liver Physiology (Online). 304, 12, p. G1117-27

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Characterization of oral and intravenous glucose handling in truncally vagotomised subjects with pyloroplasty

    Plamboeck, A., Veedfald, S., Deacon, C. F., Hartmann, B., Wettergren, A., Svendsen, L. B., Meisner, S., Hovendal, C., Knop, F. K., Vilsbøll, T. & Holst, J. J., 23 May 2013, In : European Journal of Endocrinology. 169, 2, p. 187-201

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects

    Knop, F. K., Konings, E., Timmers, S., Schrauwen, P., Holst, J. & Blaak, E. E., 11 May 2013, In : Diabetic Medicine Online. 30, 10, 1214-1218, p. 1214-1218

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease

    Idorn, T., Knop, F. K., Jørgensen, M., Holst, J. J., Hornum, M. & Feldt-Rasmussen, B., May 2013, In : Kidney International. 83, 5, p. 915-23 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

    Calanna, S., Christensen, M., Holst, J., Laferrère, B., Gluud, L. L., Vilsbøll, T. & Knop, F. K., May 2013, In : Diabetologia Praktyczna. 56, 5, p. 965-72 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published
  11. Published

    Psoriasis er associeret med type 2-diabetes

    Gyldenløve, M., Knop, F. K., Vilsbøll, T., Zachariae, C. & Skov, L., 4 Mar 2013, In : Ugeskrift for Laeger. 175, 10, p. 652-4 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients

    Sonne, D. P., Hare, K. J., Martens, P., Rehfeld, J. F., Holst, J. J., Vilsbøll, T. & Knop, F. K., 15 Feb 2013, In : A J P: Gastrointestinal and Liver Physiology (Online). 304, 4, p. G413-9

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques

    Faurschou, A., Pedersen, J. H., Gyldenløve, M., Poulsen, S. S., Holst, J. J., Thyssen, J. P., Zachariae, C., Vilsbøll, T., Skov, L. & Knop, F. K., Feb 2013, In : Experimental Dermatology. 22, 2, p. 150-2 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations: pharmacokinetic and toxicological considerations

    Jespersen, M. J., Knop, F. K. & Christensen, M., Jan 2013, In : Expert Opinion on Drug Metabolism & Toxicology. 9, 1, p. 17-29 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele

    Færch, K. E. V., Pilgaard, K., Knop, F. K., Hansen, T., Pedersen, O., Jørgensen, T. & Holst, J., Jan 2013, In : Diabetes, Obesity and Metabolism Online. 15, 1, p. 91-5 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes

    Mari, A., Bagger, J. I., Ferrannini, E., Holst, J. J., Knop, F. K. & Vilsbøll, T., 2013, In : P L o S One. 8, 9, p. e73154

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published
  18. 2012
  19. Published

    Diabetes. Add-on to metformin in T2DM--linagliptin or glimepiride?

    Christensen, M. & Knop, F. K., Oct 2012, In : Nature Reviews Endocrinology. 8, 10, p. 576-8 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published
  21. Published

    Glukagonlignende peptid 1-analoger i behandlingen af type 2-diabetes mellitus

    Christensen, M., Vilsbøll, T. & Knop, F. K., 20 Aug 2012, In : Ugeskrift for Laeger. 174, 34, p. 1935; discussion 1935

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea

    Lund, A. & Knop, F. K., May 2012, In : Current Medical Research and Opinion. 28, 5, p. 731-6 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published
  24. Published

    The unobtainable placebo: control of independent clinical research by industry?

    Christensen, M. & Knop, F. K., 7 Jan 2012, In : Lancet. 379, 9810, p. 30

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes

    Rhee, N. A., Vilsbøll, T. & Knop, F. K., 2012, In : Diabetes, Obesity and Metabolism. 14, 4, p. 291-298

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published
  27. Published
  28. Published

    Electroretinography in healthy subjects in relation to systemic glucocorticoid intake

    Kappelgaard, P., Hansen, K. B., Vilsbøll, T., Knop, F. K. & Larsen, M., 2012, In : Documenta Ophthalmologica. 124, 1, p. 49-57 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published
  30. Published

    Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects

    Hansen, K. B., Vilsbøll, T., Bagger, J. I., Holst, J. J. & Knop, F. K., 2012, In : Journal of Clinical Endocrinology and Metabolism. 97, 4, p. 1363-70 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    Increased Levels of YKL-40 and Interleukin 6 in Patients With Chronic Pancreatitis and Secondary Diabetes

    Hansen, M., Nielsen, A. R., Vilsbøll, T., Lund, A., Krarup, T., Knop, F. K. & Vestergaard, H., 2012, In : Pancreas. 41, 8, p. 1316-8 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. 2011
  33. Published

    Gastric bypass surgery: Improving psoriasis through a GLP-1-dependent mechanism?

    Faurschou, A., Zachariae, C., Skov, L., Vilsbøll, T. & Knop, F. K., 1 Oct 2011, In : Medical Hypotheses. 77, 6, p. 1098-1101

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Regulation of glucagon secretion by incretins

    Holst, J. J., Christensen, M., Lund, A., De Heer, J. J. N., Svendsen, B. M., Kielgast, U. & Knop, F. K., Oct 2011, In : Diabetes, Obesity and Metabolism Online. 13 Suppl 1, p. 89-94 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  35. Published

    Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

    Knop, F. K., Aaboe, K., Vilsbøll, T., Vølund, A., Holst, J. J., Krarup, T. & Madsbad, S., Jul 2011, In : Diabetes, Obesity and Metabolism. 14, 6, p. 500-510

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published

    Inhibition of glucagon secretion by GLP-1 agonists and DPP4 inhibitors

    Hansen, M., Holst, J. J. & Knop, F. K., Jun 2011, In : Journal of Clinical Metabolism & Diabetes. 2, 1, p. 7-13

    Research output: Contribution to journalReviewResearchpeer-review

  37. Published

    Gastric emptying of orally administered glucose solutions and incretin hormone responses are unaffected by laparoscopic adjustable gastric banding

    Usinger, L., Hansen, K. B., Kristiansen, V. B., Larsen, S., Holst, J. J. & Knop, F. K., 1 May 2011, In : Obesity Surgery. 21, 5, p. 625-32 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  38. Published

    Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes

    Holst, J. J., Knop, F. K., Vilsbøll, T., Krarup, T. & Madsbad, S., 1 May 2011, In : Diabetes Care. 34 Suppl 2, p. S251-7

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published
  40. Published

    Lixisenatide for type 2 diabetes mellitus

    Christensen, M., Knop, F. K., Vilsbøll, T. & Holst, J. J., 1 Apr 2011, In : Expert Opinion on Investigational Drugs. 20, 4, p. 549-57 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  41. Published

    Inhibition de la sécrétion du glucagon par les antagonistes du GLP-1 et les inhibiteurs de la DPP-4

    Hansen, M., Knop, F. K. & Holst, J. J., Apr 2011, In : Medecine des Maladies Metaboliques. 5, 2

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published
  43. Published

    Impaired regulation of the incretin effect in patients with type 2 diabetes

    Bagger, J. I., Knop, F. K., Lund, A., Vestergaard, H., Holst, J. J. & Vilsbøll, T., 1 Mar 2011, In : The Journal of clinical endocrinology and metabolism. 96, 3, p. 737-45 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  44. Published
  45. Published

    2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans

    Hansen, K. B., Rosenkilde, M. M., Knop, F. K., Wellner, N., Diep, T. A., Rehfeld, J. F., Andersen, U. B., Holst, J. J. & Hansen, E. H., 2011, In : Journal of Clinical Endocrinology and Metabolism. 96, 9, p. E1409-17

    Research output: Contribution to journalJournal articleResearchpeer-review

  46. Published

    Emerging GLP-1 receptor agonists

    Lund, A., Knop, F. K. & Vilsbøll, T., 2011, In : Expert Opinion on Emerging Drugs. 16, 4, p. 607-18 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    First case associating chronic pancreatitis and Ehlers-Danlos syndrome

    Hansen, K. B. & Knop, F. K., 2011, In : Pancreas. 40, 1

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    Glucagon antagonism as a potential therapeutic target in type 2 diabetes

    Bagger, J. I., Knop, F. K., Holst, J. J. & Vilsbøll, T., 2011, In : Diabetes, Obesity and Metabolism. 13, 11, p. 965-71 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans

    Christensen, M., Vedtofte, L., Holst, J. J., Vilsbøll, T. & Knop, F. K., 2011, In : Diabetes. 60, 12, p. 3103-9 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  50. Published

    Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide

    Faurschou, A., Knop, F. K., Thyssen, J. P., Zachariae, C., Skov, L. & Vilsbøll, T., 2011, In : Acta Diabetologica.

    Research output: Contribution to journalJournal articleResearchpeer-review

  51. Published

    The alpha-cell as target for type 2 diabetes therapy

    Christensen, M., Bagger, J. I., Vilsboll, T. & Knop, F. K., 2011, In : Review of Diabetic Studies. 8, 3, p. 369-81 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  52. Published

    Therapy for obesity based on gastrointestinal hormones

    Bagger, J. I., Christensen, M., Knop, F. K. & Vilsboll, T., 2011, In : Review of Diabetic Studies. 8, 3, p. 339-47 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  53. 2010
  54. Published

    Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes

    Jimenez-Solem, E., Rasmussen, M. H., Christensen, M. & Knop, F. K., 1 Dec 2010, In : Current Opinion in Molecular Therapeutics. 12, 6, p. 790-7 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 31007257